Authors


Jeremy B. Sussman, MD, MS

Latest:

Cardiac Risk Is Not Associated With Hypertension Treatment Intensification

This study shows how cardiovascular prevention would be much more efficient if risk were used in treatment decisions, but that currently it plays no role.




Seth Joseph, MBA

Latest:

A Better Way: Leveraging a Proven and Utilized System for Improving Current Medication Reconciliation Processes

In this reply to the commentary, “A Call for a Statewide Medication Reconciliation Program,” published in the October 2016 issue of The American Journal of Managed Care®, authors discuss a proven and scalable solution to improve medication reconciliation that is already available to, and used by, clinicians.



Lynn L. DeBar, PhD, MPH

Latest:

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.



Marsha A. Raebel, PharmD

Latest:

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.




Karen Chan Osilla, PhD

Latest:

Systematic Review of the Impact of Worksite Wellness Programs

Analysis of studies of worksite wellness programs suggested mixed impact on health-related behaviors and cost, with insufficient evidence regarding absenteeism and mental health.


Lewis E. Kazis, ScD

Latest:

Predictors of High-Risk Prescribing Among Elderly Medicare Advantage Beneficiaries

This study examines patterns of high-risk prescribing in the elderly Medicare Advantage population and demonstrates that the practice varies widely by geography and drug class.


Chieh-I Chen, MPH

Latest:

Utilization Management for Smoking Cessation Pharmacotherapy: Varenicline Rejected Claims Analysis

About half of the patients in this study did not fill any smoking cessation medication following a rejected claim for varenicline.


Stacy Kelley, MPH

Latest:

Project ECHO: An Effective Means of Increasing Palliative Care Capacity

This article provides insight on the work of 7 of Project ECHO’s replicating partners from around the world who are implementing the ECHO model to address the knowledge gap that underlies integrated palliative care crisis.


Gerald F. Kominski, PhD

Latest:

The Effect of Disease Management on Utilization of Services by Race/Ethnicity: Evidence From the Florida Medicaid Program

This study examines racial/ethnic differences in utilization of inpatient days and ED and outpatient visits before and after implementation of a Medicaid disease management program.


Steven J. Atlas, MD, MPH

Latest:

Chronic Disease Outcomes From Primary Care Population Health Program Implementation

Patients in practices with central population health coordinators had greater improvement in short-term chronic disease outcome measures compared with patients in practices without central support.



Sharron L. Docherty, PhD, PNP-BC

Latest:

The Need for a Serious Illness Digital Ecosystem (SIDE) to Improve Outcomes for Patients Receiving Palliative and Hospice Care

Palliative and hospice care services produce well-known benefits for patients living with serious illness and for their families. Benefits include improved quality of life and reduced symptom burden, spiritual and emotional distress, and caregiver distress.



Sinead McGilloway, PhD

Latest:

Psychological Family Intervention for Poorly Controlled Type 2 Diabetes

A family-based intervention targeting negative and/or inaccurate illness perceptions in patients with poorly controlled type 2 diabetes was effective in improving glycemic control.


Bix E. Swain, MS

Latest:

Medicare Part D Coverage Gap and Diabetes Beneficiaries

When diabetic patients in 2 Medicare Advantage Part D plans reached the 2006 coverage gap, overall drug costs dropped as out-of-pocket costs increased.


Stephane A. Regnier, PhD, MBA

Latest:

How Does Drug Coverage Vary by Insurance Type? Analysis of Drug Formularies in the United States

The proportion of available on-patent drugs covered in low copay tiers varied by insurance type, with the lowest proportion being in Medicare plans.





Mandy Smith Ryan, PhD

Latest:

Small Practices' Experience With EHR, Quality Measurement, and Incentives

A study to assess clinician attitudes and experiences after participating in a New York City cardiovascular disease focused quality recognition and financial incentive program using health information technology.


Zachary Goldman, MPP

Latest:

The Redesign of Consumer Cost Sharing for Specialty Drugs at the California Health Insurance Exchange

Patients can be shielded from the most onerous cost-sharing burdens for specialty drugs while keeping premiums affordable for the entire enrolled population.


Thomas P. Sellers, MPA

Latest:

Journey Forward: The New Face of Cancer Survivorship Care

WellPoint, UCLA's Jonsson Comprehensive Cancer Center, the National Coalition for Cancer Survivorship (NCCS) and Genentech collaborated to develop Journey Forward, a first-of-its-kind program for coordinating post-treatment care.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo